Physician

Devendra Kanaiyalal Amin, MD

According to 2025 Medicare claims, Devendra Amin, MD (NPI: 1760452973) practices cardiology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Northampton, PA. This provider's primary affiliated billing organization is DEVENDRA K AMIN MD, PC (NPI: 1518004431; TIN: 232740332) and primary practice location at 18045-8347.

Amin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 634 traditional Medicare patients, billed 8,560 HCPCS/CPT codes, and received $418,099 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 8,557 prescription claims across 770 beneficiaries totaling $2,328,141 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 38 claims. Open Payments data shows 83 records totaling $1,955. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $1,340,932 to $418,099. In contrast, Part D prescription costs have moved sharply higher in recent years, from $808,921 to $2,328,141. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $3,698 and ending at $4,655.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,114	15,592	$1,340,932
2016	1,912	12,621	$1,113,725
2017	1,892	10,863	$887,217
2018	1,241	9,684	$861,705
2019	1,056	9,031	$682,435
2020	899	6,503	$479,129
2021	825	6,147	$497,723
2022	752	4,878	$399,476
2023	695	7,923	$514,131
2024	634	8,560	$418,099

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	777	10,880	$808,921
2016	846	10,817	$772,327
2017	846	10,877	$865,264
2018	796	9,684	$889,036
2019	805	8,870	$998,161
2020	771	8,703	$1,156,520
2021	773	8,666	$1,515,557
2022	764	8,324	$1,820,037
2023	764	8,402	$1,813,138
2024	770	8,557	$2,328,141

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,445
2016	N/R	12	$924
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$285
2020	N/R	38	$626
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	190	191	$333
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	248	253	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	616	1,686	$95
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	190	191	$51
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	191	192	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	652	32,508	$611,638
Vyndamax	Tafamidis	19	810	$610,208
Jardiance	Empagliflozin	290	16,648	$315,722
Entresto	Sacubitril/Valsartan	192	10,662	$218,441
Xarelto	Rivaroxaban	108	7,495	$134,894

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$1,955	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Devendra Kanaiyalal Amin, MD?

Tedicare shows public-source Medicare data for Devendra Kanaiyalal Amin, MD (NPI 1760452973), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devendra Kanaiyalal Amin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Devendra Kanaiyalal Amin, MD?

Devendra Kanaiyalal Amin, MD is linked to DEVENDRA K AMIN MD, PC (billing NPI 1518004431) in the available physician profile data.

Does Devendra Kanaiyalal Amin, MD have Open Payments data?

Devendra Kanaiyalal Amin, MD has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.